Bevacizumab and irinotecan in patients with recurrent glioblastoma (GBM): Results of a retrospective cohort study of the OMIT Bretagne and Pays de la Loire.
F. Grude
No relevant relationships to disclose
M. Campone
No relevant relationships to disclose
J. Frenel
No relevant relationships to disclose
P. Soulie
No relevant relationships to disclose
E. Vauleon
No relevant relationships to disclose
Y. Hadjarab
No relevant relationships to disclose
G. Ganem
No relevant relationships to disclose
F. Denis
No relevant relationships to disclose
J. Egreteau
No relevant relationships to disclose
A. Lortholary
No relevant relationships to disclose
M. Porneuf
No relevant relationships to disclose
H. Simon
No relevant relationships to disclose
P. Dam Hieu
No relevant relationships to disclose
V. Klein
No relevant relationships to disclose
B. Dominique
No relevant relationships to disclose
P. Deguiral
No relevant relationships to disclose
H. Desclos
No relevant relationships to disclose
P. Menei
No relevant relationships to disclose
S. Traoré
No relevant relationships to disclose